A share price of Palvella Therapeutics Inc [PVLA] is currently trading at $105.83, up 5.55%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PVLA shares have gain 15.02% over the last week, with a monthly amount glided 7.96%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Palvella Therapeutics Inc [NASDAQ: PVLA] stock has seen the most recent analyst activity on December 05, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $167. Previously, Craig Hallum started tracking the stock with Buy rating on December 04, 2025, and set its price target to $175. On November 19, 2025, upgrade upgraded it’s rating to Strong Buy but maintained its price target of $143 on the stock. Oppenheimer started tracking the stock assigning an Outperform rating and suggested a price target of $85 on September 09, 2025. Raymond James initiated its recommendation with an Outperform and recommended $54 as its price target on August 06, 2025. Truist started tracking with a Buy rating for this stock on July 21, 2025, and assigned it a price target of $56. In a note dated April 09, 2025, Chardan Capital Markets initiated a Buy rating and provided a target price of $50 on this stock.
Palvella Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $11.17 and $114.69. Currently, Wall Street analysts expect the stock to reach $184.18 within the next 12 months. Palvella Therapeutics Inc [NASDAQ: PVLA] shares were valued at $105.83 at the most recent close of the market. An investor can expect a potential return of 74.03% based on the average PVLA price forecast.
Analyzing the PVLA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -0.73 and Total Capital is -0.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 102.07 points at the first support level, and at 98.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 108.80, and for the 2nd resistance point, it is at 111.77.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Palvella Therapeutics Inc [NASDAQ:PVLA] is 6.49. Also, the Quick Ratio is 6.49, while the Cash Ratio stands at 6.16. Considering the valuation of this stock, the price to sales ratio is 927.89, the price to book ratio is 30.34.
Transactions by insiders
Recent insider trading involved Goin Kathleen, Chief Operating Officer, that happened on Dec 17 ’25 when 4302.0 shares were sold. Officer, Goin Kathleen completed a deal on Dec 17 ’25 to buy 4302.0 shares. Meanwhile, Chief Operating Officer Goin Kathleen sold 4302.0 shares on Nov 19 ’25.
